Shiqing Chen

1.7k total citations · 1 hit paper
66 papers, 860 citations indexed

About

Shiqing Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shiqing Chen has authored 66 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Shiqing Chen's work include Cancer Immunotherapy and Biomarkers (19 papers), Cancer Genomics and Diagnostics (15 papers) and Lung Cancer Treatments and Mutations (11 papers). Shiqing Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Cancer Genomics and Diagnostics (15 papers) and Lung Cancer Treatments and Mutations (11 papers). Shiqing Chen collaborates with scholars based in China, United States and Ethiopia. Shiqing Chen's co-authors include Yuezong Bai, Shangli Cai, Jia Song, Xiaochen Zhao, Zhengyi Zhao, Mengli Huang, Yuzi Zhang, Guoqiang Wang, Longgang Cui and Qīng Wáng and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shiqing Chen

63 papers receiving 855 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer

2019 249 citations Xiaochen Zhao, Shangli Cai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shiqing Chen China	12	490	258	218	119	104	66	860
Li-Ching Lin Taiwan	20	315 0.6×	153 0.6×	393 1.8×	204 1.7×	56 0.5×	27	890
Xiaohua Gong United States	13	307 0.6×	111 0.4×	244 1.1×	52 0.4×	184 1.8×	29	756
Hui Wei China	19	229 0.5×	85 0.3×	453 2.1×	187 1.6×	105 1.0×	119	1.0k
Jianhua Wu China	16	260 0.5×	232 0.9×	437 2.0×	321 2.7×	110 1.1×	34	847
Michael J. Beckman United States	13	291 0.6×	312 1.2×	248 1.1×	170 1.4×	147 1.4×	20	924
Limin Sun China	15	287 0.6×	65 0.3×	446 2.0×	179 1.5×	63 0.6×	28	729
Sevtap Savas Canada	19	256 0.5×	114 0.4×	664 3.0×	232 1.9×	47 0.5×	69	1.1k
Li‐ping Gong China	16	199 0.4×	65 0.3×	311 1.4×	265 2.2×	82 0.8×	43	717
Shiyu Jiang China	13	376 0.8×	242 0.9×	209 1.0×	78 0.7×	86 0.8×	54	767

Countries citing papers authored by Shiqing Chen

Since Specialization

Citations

This map shows the geographic impact of Shiqing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiqing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiqing Chen more than expected).

Fields of papers citing papers by Shiqing Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiqing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiqing Chen. The network helps show where Shiqing Chen may publish in the future.

Co-authorship network of co-authors of Shiqing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shiqing Chen. A scholar is included among the top collaborators of Shiqing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiqing Chen. Shiqing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yuhao, Ligang Yang, Chu Chu, et al.. (2024). Normal fat intake with high MUFA content and an appropriate SFA/MUFA/PUFA ratio improved the health of rats. European Journal of Lipid Science and Technology. 126(6). 1 indexed citations

Yan, Kai, Ding Zhang, Yanan Chen, et al.. (2023). Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma. Frontiers in Immunology. 14. 1116057–1116057. 3 indexed citations

Qi, Changsong, Yuezong Bai, Hui Chen, et al.. (2023). China special issue on gastrointestinal tumors—NTRK fusion in a large real‐world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment. International Journal of Cancer. 153(11). 1916–1927. 2 indexed citations

Wang, Xiangyu, Rui Zhang, Jiahao Han, et al.. (2023). Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases: A Prospective Study. Annals of Surgical Oncology. 30(8). 5252–5263. 8 indexed citations

Cao, Guangming, Jinfeng Li, Bin Zhang, et al.. (2023). Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study. Frontiers in Immunology. 14. 1022942–1022942. 9 indexed citations

Ju, Wu‐tong, Ronghui Xia, Dongwang Zhu, et al.. (2022). A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nature Communications. 13(1). 78 indexed citations

Chong, Xiaodan, Jingde Chen, Nanxin Zheng, et al.. (2022). PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN. Molecular Cancer. 21(1). 118–118. 28 indexed citations

Yan, Zhengqing, et al.. (2022). Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report. Frontiers in Oncology. 12. 778545–778545. 5 indexed citations

Li, Ye, Rujiao Liu, Zhengqing Yan, et al.. (2022). Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy. Frontiers in Oncology. 12. 830816–830816. 8 indexed citations

10.

Song, Zhengbo, Dongqing Lv, Shiqing Chen, et al.. (2021). Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial. Clinical Cancer Research. 28(3). 461–467. 31 indexed citations

11.

Liang, Yan, Wěi Li, Zhengyi Zhao, et al.. (2021). The role of TGF-β pathway alterations in immune regulation as a potential pan-cancer biomarker in immunotherapy. Annals of Translational Medicine. 9(22). 1660–1660. 1 indexed citations

12.

Li, Xiao, et al.. (2021). Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report. Frontiers in Oncology. 11. 596342–596342. 4 indexed citations

13.

Peng, Ling, Qiqi Mao, Bo Jiang, et al.. (2020). Bilateral Posterior Uveitis and Retinal Detachment During Immunotherapy: A Case Report and Literature Review. Frontiers in Oncology. 10. 549168–549168. 9 indexed citations

14.

Wang, Longrong, Kai Yan, Xigan He, et al.. (2020). LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. Journal of Cancer. 12(1). 217–223. 36 indexed citations

15.

Liu, Fangqi, Jiang Zhao, Cong Li, et al.. (2019). The unique prognostic characteristics of tumor deposits in colorectal cancer patients. Annals of Translational Medicine. 7(23). 769–769. 36 indexed citations

16.

Li, Cong, et al.. (2019). Overexpression of CASC19 indicates poor prognosis and facilitates proliferation, migration and invasion in colorectal cancer. Translational Cancer Research. 8(4). 1249–1257. 6 indexed citations

17.

Bi, Yan, Weibo Niu, Shiqing Chen, et al.. (2017). Common variants in SLC6A2, SLC6A3, DRD2, and major depressive disorder. Psychiatric Genetics. 27(3). 103–104. 5 indexed citations

18.

Chen, Lei, Beimeng Yang, Shuai Wang, et al.. (2017). Abnormal circadian oscillation of hippocampal MAPK activity and power spectrums in NF1 mutant mice. Molecular Brain. 10(1). 29–29. 4 indexed citations

19.

Li, Xin, Yang Wang, Xingwang Li, et al.. (2012). No Association Between the USP7 Gene Polymorphisms and Colorectal Cancer in the Chinese Han Population. Asian Pacific Journal of Cancer Prevention. 13(5). 1749–1752. 1 indexed citations

20.

Chen, Shiqing. (2006). Hydrolysis of Chitin to Prepare Glucosamine Hydrochloride via Gradient Temperature-elevating Method. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact